..................................................
I will delete posts that are
solicitation from a pump site
or solicitation of us by salesmen
..................................................
$NEXCF at resistance $0.88
OTC/QB avg daily volume (low) 16k website hold x 100% sell filings and news 3/27/2020
$6 million in Revenues Period Ended December 31st 2019
$SHMP looking for a bottom $0.027
OTC/QB - made a ton of money the 1st run ($0.02)
Avg daily Volume 440k
Now looking for a bottom play re entry. A Game Changer stock.
Perfected clean "farming" of salt water shrimp and fish. Website float 300.64m
100% sell filings and news 3/18/20 a fire has destroyed the main building
Note:
We are adopting a policy
of barring and deleting paid humps and the like !!
I will delete any paid promo. They come here to make
some use of our casual stock sharing environment.
Good riddance.
Sign in the entrance window:
We will also delete any so-called market research
advertisement or any post fronting such off-site and
any off-site email sign-up or company solicitation.
< All foreign exchange stocks are welcome so long
as their exchange is clearly shown each posting.
A word to the wise:
"Stock picking is work".
"The stock market
is all about work."
"Just you and it "
We follow stocks with a low float < 100M
and stocks with an ultra low float < 30M.
But whatever is moving well, makes a1list.
Charts qualify that are looking up in some way:
on a moving average at resistance or support,
or with a staging formation such as a bull flag.
An upgrading Pr is great too.
The float shown is the highest number
from OTCMarkets-YahooFinance-WSJournal.
I use the highest of any two I look at.
Re: O/S Checked against SEC filings.
Understanding the Basics: Premiums and Deductibles Picture sorting through bills with a cup of lukewarm coffee, wondering if there’s a smarter way to handle homeowner insurance. Chuck Montgomery cuts through the fluff, talking turkey about balancing insurance dollars. One part of the game is deciding your deductible, the sum you fork over before insurance steps in...
Navigating the Clutter on Fishing Boats You ever try setting up a sonar system on a fishing boat? It's like untangling a mess of Christmas lights. The cables, the hubs, the separate units—it’s chaos. Here's where a crafty inventor from Zumbro Falls, Minnesota, steps into the ring with an idea that's as refreshing as an ice-cold beer on a summer’s day: a centralized...
Changing the Senior Living Game for Military Families Out of all the fancy talk shows and slick productions, "All Access hosted by Andy Garcia" managed to hit a real nerve on the quiet, critical shifts happening in the senior living sector. They dug into how Air Force Enlisted Village in Shalimar is taking care of our military families' unsung heroes—the surviving...
Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...
Throwing a Sweet Deal for New Franchise Owners Talk about a move that’s got the industry buzzing—Famous Brands International, the folks behind Mrs. Fields and TCBY, just rolled out a tantalizing offer you don’t see every day. They’re slashing franchise fees and royalties by half for new franchisees who jump onboard before the ball drops on 2026. I’ll tell ya,...
Omega-3s and Child Development: Why the Buzz? Alright, let's dig into a study that's grabbing attention: it's all about how those little omega-3 fatty acids, the kind found in walnuts and fish, might just be crafting our kids into brainiacs. The latest research published in the European Journal of Epidemiology connects these fatty acids to cognitive prowess from childhood...
Universal's Harmonious Growth in 2026 Universal Music Group (UMG) isn't just playing second fiddle to anyone in the music biz. They've rolled out an impressive set of numbers for Q3 2026. We're talking €3,394 million in revenue, marking a solid 12.3% bump year-over-year, or 11.7% when the currency takes a breather. Hats off to the acquisition of Downtown, which greased...
Veralto's Stellar Third Quarter Performance Jumping right into the thick of it, Veralto's third quarter 2026 numbers aren't just a flash in the pan. We're talking a solid sales boost of 7.5%, reaching the magic number of $1,509 million. If you're holding NYSE:VLTO, these figures are a good look. It's not every day you see an operating profit margin hovered at an...
Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...
Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...
Election Results Signal a Continued Reform Agenda Recently held elections have decisively propelled Uzbekistan’s reform agenda forward. The results released by the Central Election Commission show the Liberal Democratic Party has emerged triumphant, expanding its representation in the Oliy Majlis, the country’s parliament. This significant win solidifies the ongoing...
Coral Energy Responds to Misleading Claims in Le Monde Article Recently, Coral Energy has issued a strong statement in response to misleading claims published in a prominent article by Le Monde. The company firmly denies the inaccuracies and unverified allegations presented in the article, which failed to recognize Coral's commitment to compliance and ethical practices....
Accent Therapeutics Unveils Promising Cancer Trials Accent Therapeutics has pioneered a Phase 1/2 study for ATX-295, a novel oral inhibitor of KIF18A aimed at tackling advanced solid tumors like ovarian cancer. The FDA has awarded Fast Track designation to Accent's leading clinical candidates, ATX-295 and ATX-559, enhancing their potential to treat adults facing...
Innovative EdTech Fellowship Unveiled for MENA Leaders In a significant move to enhance education throughout the Middle East and North Africa, Cambridge University Press & Assessment (Cambridge) and HP Inc. have launched a new Education Technology (EdTech) Fellowship. This initiative aims to empower education leaders by integrating advanced technologies, such as...
Exciting Developments in Atopic Dermatitis Treatment AMGEN is taking monumental steps in the field of dermatology with their recent announcement regarding Rocatinlimab, a drug that shows great promise for those suffering from moderate to severe atopic dermatitis. The results from the Phase 3 IGNITE study underscore a significant advancement in the management of this...